The current invention relates to: procoagulant proteins which may, for example, be fusion proteins or chemical conjugates methods of producing said procoagulant proteins polynucleotides that encode said fusion proteins and cells that expresses them. Furthermore, the current invention relates to procoagulant proteins for use as a medicament. Individuals that have a coagulopathy, such as haemophilia A and B with or without inhibitors, may be treated with the procoagulant proteins of the current invention.